Literature DB >> 2450709

Purification of hnRNP from HeLa cells with a monoclonal antibody and its application in ELISA: detection of autoantibodies.

C Gelpi1, J L Rodriguez-Sanchez, J A Hardin.   

Abstract

HnRNP antigen from HeLa cells was purified using a monoclonal antibody (383 IgM) that recognizes heterogeneous nuclear ribonucleoprotein (hnRNP). From extracts of HeLa cells radiolabelled with 32P, this antibody immunoprecipitates relatively large RNAs of heterogeneous size which are synthesized in the presence of actinomycin D at doses which suppress synthesis of ribosomal RNAs (characteristic features of heterogeneous nuclear RNA). In immunoblots, 383 IgM binds to seven polypeptides: one of approximately 23,000 daltons, three between 30,000 and 43,000 daltons which correspond to the known hnRNP polypeptides called A1, A2 and C1, one of approximately 50,000 daltons, and a doublet of approximately 120,000 daltons. These proteins comigrate through sucrose density gradients suggesting that they are physically associated. Thus, 383 IgM appears to define an epitope that is shared among a number of the protein components of hnRNP. This antibody has been used to design a simple and fast protocol which allows the determination of autoantibodies from human sera by ELISA.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2450709      PMCID: PMC1541440     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Identification and characterization of the packaging proteins of core 40S hnRNP particles.

Authors:  A L Beyer; M E Christensen; B W Walker; W M LeStourgeon
Journal:  Cell       Date:  1977-05       Impact factor: 41.582

3.  Characterization of the non-histone nuclear proteins associated with rapidly labeled heterogeneous nuclear RNA.

Authors:  J Karn; G Vidali; L C Boffa; V G Allfrey
Journal:  J Biol Chem       Date:  1977-10-25       Impact factor: 5.157

4.  Proteins associated with heterogeneous nuclear RNA in eukaryotic cells.

Authors:  T Pederson
Journal:  J Mol Biol       Date:  1974-02-25       Impact factor: 5.469

5.  Characterization of heterogeneous nuclear RNA-protein complexes in vivo with monoclonal antibodies.

Authors:  G Dreyfuss; Y D Choi; S A Adam
Journal:  Mol Cell Biol       Date:  1984-06       Impact factor: 4.272

6.  Molecular characterization of ribonucleoprotein antigens bound by antinuclear antibodies. A diagnostic evaluation.

Authors:  L Matter; K Schopfer; J A Wilhelm; T Nyffenegger; R F Parisot; E M De Robertis
Journal:  Arthritis Rheum       Date:  1982-11

7.  Antibodies to histones in systemic lupus erythematosus: localization of prominent autoantigens on histones H1 and H2B.

Authors:  J A Hardin; J O Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

8.  Antibodies to heterogeneous nuclear ribonucleoproteins in sera from patients with rheumatic autoimmune diseases.

Authors:  M Zouali; A Eyquem
Journal:  J Clin Immunol       Date:  1984-05       Impact factor: 8.317

9.  Monoclonal antibodies to heterogeneous nuclear RNA-protein complexes. The core proteins comprise a conserved group of related polypeptides.

Authors:  G P Leser; J Escara-Wilke; T E Martin
Journal:  J Biol Chem       Date:  1984-02-10       Impact factor: 5.157

10.  A nuclear antigen associated with cell proliferation and blast transformation.

Authors:  Y Takasaki; J S Deng; E M Tan
Journal:  J Exp Med       Date:  1981-12-01       Impact factor: 14.307

View more
  2 in total

1.  Recognition of subsets of the mammalian A/B-type core heterogeneous nuclear ribonucleoprotein polypeptides by novel autoantibodies.

Authors:  A Dangli; A Plomaritoglou; E Boutou; N Vassiliadou; H M Moutsopoulos; A Guialis
Journal:  Biochem J       Date:  1996-12-15       Impact factor: 3.857

2.  Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex.

Authors:  G Steiner; K Hartmuth; K Skriner; I Maurer-Fogy; A Sinski; E Thalmann; W Hassfeld; A Barta; J S Smolen
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.